1-4 of 4
Debra A. Wolff, MS, PCNP
Close
Sort by
Journal Articles

Prospective Validation of a Predictive Model for Early Anemia in Patients Receiving Cancer Chemotherapy.

Gary H. Lyman, MD, MPH, FRCP, David C. Dale, MD, Nicole M. Kuderer, MD, Debra A. Wolff, MS, PCNP, Eva Culakova, PHD, Marek S. Poniewierski, MD, MS, Jeffrey Crawford, MD, for the ANC Study Group
Journal: Blood
Blood (2006) 108 (11): 460.
https://doi.org/10.1182/blood.V108.11.460.460
Published: 2006
Journal Articles

Predicting the Risk of Neutropenic Complications and Reduced Dose Intensity in Patients with Malignant Lymphoma: Results from a Prospective Study.

David C. Dale, MD, Jeffrey Crawford, MD, Debra A. Wolff, MS, PCNP, Marek S. Poniewierski, MD, MS, Eva Culakova, PHD, Gary H. Lyman, MD, MPH, for the ANC Study Group
Journal: Blood
Blood (2004) 104 (11): 4599.
https://doi.org/10.1182/blood.V104.11.4599.4599
Published: 2004
Journal Articles

Assessment of Hematologic and Non-Hematologic Toxicity in Older Cancer Patients Receiving Systemic Chemotherapy: Results from a Prospective Nationwide Registry.

Naeem Tahir, MD, Jerome H. Goldschmidt, MD, Eva Culakova, PHD, Marek S. Poniewierski, MD, MS, Debra A. Wolff, MS, PCNP, David C. Dale, MD, Jeffrey Crawford, MD, Gary H. Lyman, MD, MPH
Journal: Blood
Blood (2004) 104 (11): 3131.
https://doi.org/10.1182/blood.V104.11.3131.3131
Published: 2004
Journal Articles

First Cycle Risk of Severe and Febrile Neutropenia in Cancer Patients Receiving Systemic Chemotherapy: Results from a Prospective Nationwide Study.

Jeffrey Crawford, MD, Debra A. Wolff, MS, PCNP, Eva Culakova, PhD, Marek S. Poniewierski, MD, MS, Caleb Selby, David C. Dale, MD, Gary H. Lyman, MD, MPH, for the ANC Study Group
Journal: Blood
Blood (2004) 104 (11): 2210.
https://doi.org/10.1182/blood.V104.11.2210.2210
Published: 2004